Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjhemonc logo
VJRegenMed
Logo
  • Home (current)
  • Specialties
    Hematology
    Oncology
    Musculoskeletal Disorder
    Rare Disease
    Metabolic Disorder
    Cardiovascular Disease
    Ophthalmology
    Neurology
    Infectious Disease
    View all Specialties
  • Technologies
    Cell Therapy
    MSC
    iPSC
    Gene Therapy
    Genome Editing
    Extracellular Vesicles
    CAR-T Therapy
    TCR Therapy
    Tissue-Engineering & Biomaterials
    View all Technologies
  • Topics
    Treatment
    Immuno-Oncology
    Trial Updates
    Perspectives
    Manufacturing
    COVID-19
    View all Topics
  • Conferences
    ASH 2022
    TCT 2022
    Meeting on the Med 2022
    ICLE 2022
    Advanced Therapies Week 2022
    TERMIS 2021
    ESGCT 2021
    Meeting on the Mesa 2021
    Advanced Therapies 2021
    View all Conferences
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Meeting on the Med 2022

Treating otoferlin deficiency with gene therapy 2:51
Treating otoferlin deficiency with gene therapy
Nawal Ouzren • 26 Apr 2022
Novel gene therapy solutions for Usher syndrome type I 2:05
Novel gene therapy solutions for Usher syndrome type I
Nawal Ouzren • 26 Apr 2022
Developing gene therapies for GJB2 gene related hearing loss 1:59
Developing gene therapies for GJB2 gene related hearing loss
Nawal Ouzren • 26 Apr 2022
CYP-001 in adults with steroid-resistant GvHD 3:00
CYP-001 in adults with steroid-resistant GvHD
Ross Macdonald • 19 Apr 2022
SCUlpTOR: CYP-004 in osteoarthritis 2:56
SCUlpTOR: CYP-004 in osteoarthritis
Ross Macdonald • 19 Apr 2022
Plasmacytoid dendritic cell-based cancer vaccines 1:43
Plasmacytoid dendritic cell-based cancer vaccines
Eric Halioua • 20 Apr 2022
Developing a therapeutic cancer vaccine for patients with NSCLC 2:41
Developing a therapeutic cancer vaccine for patients with NSCLC
Eric Halioua • 20 Apr 2022
Assessing PDC*mel, dendritic cell-based vaccine in melanoma 1:34
Assessing PDC*mel, dendritic cell-based vaccine in melanoma
Eric Halioua • 20 Apr 2022
Addressing challenges in using MSCs in cell therapies 3:00
Addressing challenges in using MSCs in cell therapies
Ross Macdonald • 19 Apr 2022
Generating iSPC-derived MSCs with the Cymerus™ Platform 2:34
Generating iSPC-derived MSCs with the Cymerus™ Platform
Ross Macdonald • 19 Apr 2022
The future of omentum-based autologous tissue engineering 1:01
The future of omentum-based autologous tissue engineering
Asaf Toker • 19 Apr 2022
Autologous tissue-engineered solutions for spinal cord injuries 2:36
Autologous tissue-engineered solutions for spinal cord injuries
Asaf Toker • 19 Apr 2022
Restoring cardiac tissue with omentum-based hydrogel implants 1:35
Restoring cardiac tissue with omentum-based hydrogel implants
Asaf Toker • 19 Apr 2022
Journal Pages
  • Specialties
  • Technologies
  • Topics
  • Conferences
Newsletter

Receive the latest news and videos from VJRegenMed via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJRegenMed logo
The content of VJRegenMed is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy